Merck

Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.

Email Format

{first_name}_{last_name}@merck.com — 85.7%

sarah_smith@merck.com

{first_name}.{last_name}@merck.com — 8.6%

sarah.smith@merck.com

{first_name}{first_letter_last_name}@merck.com — 2.9%

sarahs@merck.com

{first_name}{last_name}@merck.com — 2.9%

sarahsmith@merck.com

Key Employees

Contact details of 5 Merck executives

Phillip Samayoa

Associate Director, MRL Ventures
  • Work email

    p******s@merck.com

Eliav Barr

Vice President, Infectious Diseases
  • Work email

    e********r@merck.com

Dean Li

Senior Vice President of Discovery Sciences and Translational Medicine
  • Work email

    d****i@merck.com

Marc Gailhardou

a VP Global Oncology Strategy at Merck
  • Work email

    m*************u@merck.com

Per Lofberg

Founder

Other Employees

Contact details of 35 Merck other employees

Joseph Schaller

Job not specified
  • Work email

    j*************r@merck.com

Peter Honigmann

Job not specified
  • Work email

    p*************n@merck.com

Rob Davis

Job not specified
  • Work email

    r*******s@merck.com

Renee Suhr

Job not specified
  • Work email

    r********r@merck.com

Caroline Litchfield

Job not specified
  • Work email

    c*****************d@merck.com

Todd Herman

Job not specified
  • Work email

    t*********n@merck.com

Eunkyung Kauh

Job not specified
  • Work email

    e***********h@merck.com

Cameron Downie

Job not specified
  • Work email

    c************e@merck.com

Martin Khun

Job not specified
  • Work email

    m*********n@merck.com

Joe Volpe

Job not specified
  • Work email

    j**********e@merck.com

Lubomir Kamensky

Job not specified
  • Work email

    l**************y@merck.com

Carolina Colella

Job not specified
  • Work email

    c**************a@merck.com

Rachel Parise

PhD Candidate - Analytical Chemistry Reseacher
  • Work email

    r***********e@merck.com

Peter Dudek

Associate
  • Work email

    p*********k@merck.com

Jieyun Hao

HR Business Partner
  • Work email

    j********o@merck.com

Francesca Poggio

Job not specified
  • Work email

    f**************o@merck.com

Ken Friesen

Job not specified
  • Work email

    k*********n@merck.com

Austin Snook

Job not specified
  • Work email

    a**********k@merck.com

Roberta Corsi

Job not specified
  • Work email

    r***********i@merck.com

Vishal Sahni

Venture Capital advisory committee member, Biofund II
  • Work email

    v**********i@merck.com

John Minehane

Assistant Production Manager
  • Work email

    j***********e@merck.com

Cheryl Donnelly

Job not specified
  • Work email

    c*************y@merck.com

Courtney Ronaldo

Job not specified
  • Work email

    c**************o@merck.com

Tracy Clemmer

Job not specified
  • Work email

    t************2@merck.com

Harry Herar

Sales Representative
  • Work email

    h*********r@merck.com

Andrei Manica

Job not specified
  • Work email

    a***********a@merck.com

Sergey Zverev

Job not specified
  • Work email

    s***********v@merck.com

Rehan A Khan

Job not specified
  • Work email

    r********n@merck.com

Kevin Ali

Job not specified
  • Work email

    k*******i@merck.com

Kevin Sharpe

Job not specified
  • Work email

    k**********e@merck.com

Heather Rakestraw

Job not specified
  • Work email

    h***************w@merck.com

Cedric Grand-Pierre

Job not specified
  • Work email

    c****************e@merck.com

Joyce. Pennings

Job not specified
  • Work email

    j************s@merck.com

Anneke Rietveld

Key Account Manager
  • Work email

    a*************d@merck.com

Kathleen Cuddy

Job not specified
  • Work email

    k************y@merck.com

General Emails

General company emails, e.g. customer support lines

    estanislao_meza@merck.com

    Unclassified inbox

    alain_boisvert@merck.com

    Unclassified inbox

    retailteam@merck.com

    Unclassified inbox

    rgball@merck.com

    Unclassified inbox

    kathleen.cuddy@merck.com

    Unclassified inbox

Similar Companies like Merck

HQ: North Chicago, Illinois, United States

AbbVie

abbvie.com

AbbVie is a pharmaceutical company that discovers, develops,...

HQ: North Chicago, Illinois, United States

Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals

Legal Name: AbbVie Inc.

Business Type: Public

Employees: 10001+

Rounds: Post-IPO Debt

Last Investment Activity: Mar 22, 2024

Founded Date: 2013

Number of Exits: 3

Company Type: For Profit

Stock Symbol: NYSE:ABBV

Operating Status: Active

HQ: Minneapolis, Minnesota, United States

Medtronic

medtronic.com

Medtronic develops healthcare technology solutions for vario...

HQ: Minneapolis, Minnesota, United States

Specialized In: Biotechnology, Healthcare & Medical, Health Diagnostics Medical Devices Hospitals & Clinics

Legal Name: Medtronic, plc.

Business Type: Public

Employees: 10001+

Rounds: Post-IPO Debt

Last Investment Activity: Mar 27, 2024

Founded Date: 1949

Number of Exits: 28

Company Type: For Profit

Stock Symbol: NYSE:MDT

Operating Status: Active

HQ: New York, New York, United States

Pfizer is a biopharmaceutical company that provides affordab...

HQ: New York, New York, United States

Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals

Legal Name: Pfizer Inc.

Business Type: Public

Employees: 10001+

Rounds: Post-IPO Debt

Last Investment Activity: Sep 3, 2024

Venture Stage: Early Stage Venture, Late Stage Venture, Post-Ipo, Private Equity, Seed, Venture

Founded Date: 1849

Number of Exits: 19

Company Type: For Profit

Stock Symbol: NYSE:PFE

Operating Status: Active

Investor Type: Corporate Venture Capital, Venture Capital

Company Info

Last updated: 21/08/2025

908-740-4000

Rahway, New Jersey, United States

Merck General Information

Specialization: Biotechnology, Healthcare & Medical, Pharmaceuticals
Legal Name: Merck & Co., Inc.
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Founded Date: 1891
Number of Exits: 9
Company Type: For Profit
Stock Symbol: NYSE:MRK
Operating Status: Active
Last Funding Type: Post-IPO Equity
Phone Number: 908-740-4000
Last Investment Activity: Mar 28, 2024
Investments Activity: Mar 28, 2024 Mar 27, 2024 Mar 27, 2024

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.